PO28 | Long term effectiveness and safety of venous thromboembolism with fondaparinux: data from the start registry
Background: Fondaparinux is licensed for the initial treatment of venous thromboembolism (VTE), but for its favourable characteristics it is sometimes used also long term. This study aimed to evaluate long term effectiveness and safety of fondaparinux in VTE. Methods: We performed a preliminary...
Saved in:
| Format: | Article |
|---|---|
| Language: | English |
| Published: |
PAGEPress Publications
2025-08-01
|
| Series: | Bleeding, Thrombosis and Vascular Biology |
| Subjects: | |
| Online Access: | https://www.btvb.org/btvb/article/view/289 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PO72 | Fondaparinux in patient with active tuberculosis
Published: (2025-08-01) -
PO89 | Apixaban for secondary prevention of venous thromboembolism in hemodialysis patients: pharmacokinetic profile and safety outcomes
Published: (2025-08-01) -
PO53 | Effectiveness and safety of DOACS in patients with renal transplantation
Published: (2025-08-01) -
PO73 | False-positive CT diagnosis of DVT in a patient with severe venous sequelae: a case of bilateral cellulitis
Published: (2025-08-01) -
PO50 | Treatment with BTK inhibitors in patients affected by chronic lymphocytic leukemia: safety and hemostasis
Published: (2025-08-01)